tradingkey.logo
tradingkey.logo
Search

BioMarin Pharmaceutical Inc

BMRN
Add to Watchlist
63.940USD
-1.140-1.75%
Close 09-18 16:00ET
12.39BMarket Cap
45.89P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.75%

5 Days

-2.65%

1 Month

-4.55%

6 Months

+15.35%

Year to Date

+7.59%

1 Year

+15.96%

Key Figures

65.250Open
65.290High
131.53KVolume
45.89P/E TTM
13.34P/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
65.080Prev. Close
63.840Low
8.50MTurnover
29.03P/E Static
1.96P/B
0.00%Div Yield TTM
3.42%ROA
70.98052wk High
0.08Volume Ratio
426.86MNet Profit
193.27MShares
1.3951EPS TTM
0.22Beta
4.48%ROE
49.26052wk Low
2.10%Amplitude
72.90%Gross Margin
12.39BMarket Cap
7.31Reward/Risk
2.21%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

BioMarin Pharmaceutical Inc's Score

0.00vs previous score
Forecast8.15
Financial Health8.90
Technical2.65
Valuation Dimensions7.86
Institutional Confidence10.00
Risk Assessment8.50

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
91.826Target Price
+42.48%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy88887789
Buy1313131213131213
Hold66555666
Sell00000000
Strong Sell00000000

BioMarin Pharmaceutical Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Neutral

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.23/0.69
Revenue / Forecast
989.71M/926.91M

BioMarin Pharmaceutical Inc Profile

SectorPharmaceuticals
Ticker SymbolBMRN
Number of employees3040
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.8.41%
Dodge & Cox7.54%
PRIMECAP Management Company7.34%
Vanguard Capital Management, LLC4.47%
Shareholder TypesProportion
Investment Advisor44.20%
Investment Advisor/Hedge Fund35.63%
Hedge Fund10.24%
Sovereign Wealth Fund3.90%

FAQs

What is the current price of BioMarin Pharmaceutical Inc (BMRN)?

The current price of BioMarin Pharmaceutical Inc (BMRN) is 63.94.

What is the symbol of BioMarin Pharmaceutical Inc?

The ticker symbol of BioMarin Pharmaceutical Inc is BMRN.

What is the 52-week high of BioMarin Pharmaceutical Inc?

The 52-week high of BioMarin Pharmaceutical Inc is 70.98.

What is the 52-week low of BioMarin Pharmaceutical Inc?

The 52-week low of BioMarin Pharmaceutical Inc is 49.26.

What is the market capitalization of BioMarin Pharmaceutical Inc?

The market capitalization of BioMarin Pharmaceutical Inc is 12.39B.

Is BioMarin Pharmaceutical Inc (BMRN) currently rated as Buy, Hold, or Sell?

According to analysts, BioMarin Pharmaceutical Inc (BMRN) has an overall rating of Buy, with a price target of 91.83.

What is the Earnings Per Share (EPS TTM) of BioMarin Pharmaceutical Inc (BMRN)?

The Earnings Per Share (EPS TTM) of BioMarin Pharmaceutical Inc (BMRN) is 1.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.